Skip to main content

Sarah Moyles focuses her practice on public and private mergers and acquisitions, joint ventures and corporate finance transactions, advising a range of domestic and international clients. Her work spans a range of industries including pharmaceuticals, engineering, telecommunications, real estate, financial services and business services. Sarah has broad experience working on large, complex, cross border and domestic transactions.


  • Mergers and acquisitions 
  • Joint ventures and shareholder arrangements
  • General corporate advice
  • Commercial contracts



  • Advised Rentokil Initial on the CMA mandated divestment of part of the MPCL Limited business to Rentokil Initial and subsequent sale of MPCL Limited to ServiceMaster.
  • Advised Bracco Imaging S.p.A., an Italian manufacturer of agents and tracers used in diagnostic imaging, in the $450 million acquisition of Blue Earth Diagnostics Limited from Syncona Portfolio Limited, subject to a $25 million closing adjustment.
  • Advised Rentokil Initial on its agreement with Franz Haniel & Cie GmbH to divest its 17.8% interest in CWS-boco International GmbH for €430 million.
  • Advised Cromwell European Real Estate Investment Trust on its acquisition of a portfolio of 16 properties in Poland, Finland and the Netherlands, through the purchase of shares in the property holding companies, for €324 million.
  • Advised AstraZeneca AB on its agreement with Grünenthal to divest the European rights to Nexium for an upfront payment of $700 million with further sales-related and milestone payments of up to $90 million.
  • Advised AstraZeneca AB on its agreement with Grünenthal to divest the global rights to Vimovo in all markets excluding the US and Japan for an upfront payment of $115 million and further payments up to another $17 million.
  • Advised IHG on its arrangements with French investor Convivio (formerly Foncière des Régions) to rebrand and operate 12 high-quality open hotels and one pipeline hotel in the UK following the acquisition of the hotels by Convivio from Starwood Capital Group. The transaction is being valued at approximately £858 million.
  • Advised Taiyo Nippon Sanso Corporation, a Japanese-based industrial gas producer, and its subsidiary Matheson Tri-Gas, in connection with its €5 billion acquisition of Praxair's European industrial gas business.
  • Advised AstraZeneca plc on its agreement with Grünenthal to divest rights to the migraine treatment Zomig.
  • Advised Smiths Group plc on the sale of Smiths Interconnect’s Microwave Telecoms business to Infinite Electronics Inc. for $112.5m.
  • Advised Rentokil Initial plc on its joint venture agreement with Haniel & Cie. Holding Company which created a leading provider of workwear and hygiene services in Europe with combined revenues of c. €1.1bn.
  • Advised AstraZeneca plc on the sale of its small molecule antibiotics business to Pfizer for $1.2bn.
  • Advised Smiths Group plc on the divestment of its Wallace product line to CooperSurgical, Inc. for £140 million.
  • Advised Atlas Mara Co-Nvest Limited in connection with its acquisition of BancABC, a leading multi-country, multi-service bank with operations across the Southern African Development Community which is listed on the Botswana stock exchange, with a secondary listing on the Zimbabwe stock exchange, its $300 million private placement and subsequent readmission to the London Stock Exchange.
  • Advised Atlas Mara Co-Nvest Limited in connection with its exercise of an option to acquire approximately 20.9 percent in Union Bank of Nigeria PLC from Asset Management Corporation of Nigeria.
  • Advised Platform Acquisition Holdings Limited on its $905m IPO on the London Stock Exchange, the largest new money raise in London in 2013.
  • Advised Rentokil Initial PLC on the sale of City Link Limited to Better Capital.
  • Advised Quantum Power Operations in relation to its acquisition of 100 percent of the shares of Castleway Properties Limited, giving it an indirect holding in the Evolution One Fund.
  • Advised Justice Holdings Limited, a publicly listed UK investment vehicle, on its $5bn business combination with Burger King Worldwide Holdings Inc. and related entities and subsequent listing of Burger King Worldwide, Inc.’s common stock on the NYSE.
  • Advised Palm Ventures on its acquisition of Nucleus Healthcare, a private hospital based in South Wales.
  • Advised APR Energy Cayman Limited (“APR”) and its management shareholders on the sale of APR to Horizon Acquisition Company plc for $855m.
  • Advised Justice Holdings Limited on its £900m IPO on the London Stock Exchange.
  • Fried, Frank, Haris, Shriver & Jacobson LLP, 2007-2009
  • Linklaters LLP, 2003-2007

Recognition & Leadership

  • Listed, The Legal 500 United Kingdom, Corporate and Commercial – M&A: Upper Mid-Market and Premium Deals, 2019-2022
  • Listed, IFLR1000 United Kingdom, 2016-2021
  • Member, Winning Team, M&A Advisor EMEA Corporate Growth Awards, Corporate Advisory Team of the Year, Transaction of the Year (over £500m - £1bn), Industrials Deal of the Year (over £100m - £1bn) and Utilities Deal of the Year, in each case, for Rentokil Initial plc's joint venture with Haniel & Cie. Holding Company, 2018
  • Member, Winning Team, ACG New York Champion’s Award, Consumer and Retail Products Deal of the Year (over $200mm) for Merger of Burger King and Justice Holdings Ltd., 2013
  • Member, Winning Team, M&A Deal of the Year (Over US$1 Billion), M&A Advisor Awards, 2013
  • Member, Winning Team, Consumer and Retail Products Deal of the Year (Over US$1 Billion), M&A Advisor Awards, 2013


  • Legal Practice Course, with distinction, Nottingham Law School
  • M.A., University of Oxford
  • B.A., with honors, The Queen’s College, University of Oxford
  • England and Wales